ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1767

Endothelial Cell-Driven JAG/NOTCH Signaling in Localized Scleroderma Patients

Theresa Hutchins1, Anwesha Sanyal1, Deren Esencan1 and Kathryn Torok2, 1University of Pittsburgh, Pittsburgh, PA, 2Division of Rheumatology, Scleroderma Center, Department of Pediatrics, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA, Pittsburgh, PA

Meeting: ACR Convergence 2024

Keywords: Gene Expression, Pediatric rheumatology, Scleroderma, Localized, skin

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Pediatric Rheumatology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Localized scleroderma is a rare autoimmune disease primarily affecting the skin and underlying tissue. While its exact pathogenesis remains unclear, studies suggest links to systemic sclerosis (SSc) through shared histological features and immune signatures in peripheral blood and skin.  The vascular system, particularly endothelial cells, plays a crucial role in SSc pathology, but their role in LS has not been well described. This study aims to characterize endothelial cells in LS and explore their communication with immune cells and contribution to LS pathogenesis.

Methods: Skin biopsy specimens from 27 LS patients and 17 healthy controls were subjected to single-cell RNA sequencing (scRNA-seq). Data were analyzed using the Seurat pipeline. Matrices were processed by CellRanger, converted to Seurat objects for cell annotation, and differential gene expression (DEG) and pathway analyses were performed. Endothelial cell subsets were annotated based on canonical markers, and their intercellular and intracellular interactions were analyzed using the NicheNet R package.

Results: Eight subclusters of endothelial cells were identified in the dataset (LS and healthy skin) using canonical markers (Figure 1A,B).  Most populations had a higher proportion in LS compared with HC (Figure 1C). DEG analysis revealed prominent expression of JAG1, JAG2, and NOTCH4 in the arterial and capillary endothelial cell subclusters of LS patients (Figure 2A, B, C). NicheNet analysis predicted significant JAG/NOTCH ligand-receptor interactions within the dataset, supported by a large ligand-target database (Figure 2D). Gene set enrichment analysis (GSEA) indicated that these genes are highly involved in the p53 pathway, which promotes JAG/NOTCH signaling. The upregulation of HES1 in LS cells, a target gene of the JAG/NOTCH pathway, further supports the involvement of endothelial cells in LS pathogenesis (Figure 2E). In addition, JAG1 Is predicted to interact with keratinocytes and smooth muscle cells with signals sent from endothelial cells based on our NicheNet analysis.

Conclusion: Endothelial cells in LS exhibit high expression of the JAG/NOTCH signaling pathway, facilitating communication with other cell types such as smooth muscle cells and keratinocytes. Variants of the NOTCH pathway, previously implicated in pediatric and adult systemic sclerosis, are associated with increased fibrosis and abnormal tissue repair. Similar pathogenic mechanisms may be at play in LS, highlighting the potential role of JAG/NOTCH signaling in its pathogenesis.

Supporting image 1

Figure 1: Endothelial cell subclusters in localized scleroderma.

Supporting image 2

Figure 2: JAG and NOTCH are highly expressed in localized scleroderma arterial and capillary subsets, with interactions between each other and external communication with immune and stromal cells.


Disclosures: T. Hutchins: None; A. Sanyal: None; D. Esencan: None; K. Torok: None.

To cite this abstract in AMA style:

Hutchins T, Sanyal A, Esencan D, Torok K. Endothelial Cell-Driven JAG/NOTCH Signaling in Localized Scleroderma Patients [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/endothelial-cell-driven-jag-notch-signaling-in-localized-scleroderma-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/endothelial-cell-driven-jag-notch-signaling-in-localized-scleroderma-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology